清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Irreversible Electroporation and Beta-Glucan-Induced Trained Innate Immunity for Treatment of Pancreatic Ductal Adenocarcinoma: A Phase II Study

医学 不可逆电穿孔 胃肠病学 免疫疗法 内科学 临床研究阶段 临床试验 电穿孔 癌症 外科 生物化学 基因 化学
作者
Robert C.G. Martin,Yan Li,Emily A. Shore,Danial A. Malik,Hong Li,Xiao Hu,Traci Hayat,Min Tan,Kelly M. McMasters,Jun Yan
出处
期刊:Journal of The American College of Surgeons [Lippincott Williams & Wilkins]
卷期号:240 (4): 351-361 被引量:2
标识
DOI:10.1097/xcs.0000000000001291
摘要

BACKGROUND: Irreversible electroporation (IRE) has augmented the effects of certain immunotherapies in pancreatic ductal adenocarcinoma (PDA). Yeast-derived particulate beta-glucan induces trained innate immunity and successfully reduced murine pancreatic cancer burden. This is a phase II study to test the hypothesis that IRE may augment beta-glucan-induced trained immunity in patients with PDA. STUDY DESIGN: In this phase II clinical trial (NCT03080974), surgical ablative IRE was performed on clinical stage III PDA followed by oral beta-glucan administration for 12 months or until disease recurrence. Peripheral blood was taken preoperative, 14 days, and every 3 months and was evaluated by mass cytometry and compared with patients who received IRE alone. RESULTS: Thirty consecutive patients with preoperative clinical stage III PDA were treated with IRE and then initiated on oral beta-glucan postoperatively were compared with 20 patients treated with IRE alone. There were no dose-limiting toxicities with oral beta-glucan, and compliance with therapy was 96% in all patients. Seven patients (23%) developed grade 3 or 4 treatment-related adverse events at 90 days; none required a dose modification of oral beta-glucan. A median disease-free interval (DFI) was 18 months (range 6 to 48 months), with a median overall survival (OS) of 32.5 months (range 4 to 53 months). At 12 months post-IRE, immunophenotyping was demonstrated a significant effect with improvement in the IRE-beta-glucan-treated group. This also resulted in a significant decrease on naive CD4 and CD8 T cells with increased CD4 and CD8 terminal effector cells in the IRE-beta-glucan-treated group, which correlated with a significant improvement in DFI and OS (p = 0.001). CONCLUSIONS: Combined beta-glucan with IRE-ablated PDA tumor cells elicited a potent trained response and augmented antitumor functionality at 12 months post-IRE, which translated into an improved DFI and OS.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
9秒前
crz完成签到,获得积分10
10秒前
噗愣噗愣地刚发芽完成签到 ,获得积分10
12秒前
13秒前
wszl发布了新的文献求助10
17秒前
科研通AI6.2应助wszl采纳,获得10
25秒前
英俊的铭应助胸外科新手采纳,获得10
26秒前
wszl完成签到,获得积分20
32秒前
文静灵阳完成签到 ,获得积分10
33秒前
梦桃完成签到 ,获得积分10
51秒前
1分钟前
1分钟前
博弈完成签到 ,获得积分10
1分钟前
11111111发布了新的文献求助10
1分钟前
跳跃的鹏飞完成签到 ,获得积分0
1分钟前
话说dota完成签到 ,获得积分10
1分钟前
激动的曼梅完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
11111111完成签到,获得积分10
2分钟前
oylonq完成签到,获得积分10
2分钟前
keke完成签到,获得积分10
2分钟前
wrl2023完成签到,获得积分10
2分钟前
dbc1234完成签到,获得积分10
2分钟前
眯眯眼的安雁完成签到 ,获得积分10
2分钟前
Jameson完成签到,获得积分10
2分钟前
zyjsunye完成签到 ,获得积分10
2分钟前
少少完成签到 ,获得积分10
3分钟前
3分钟前
小蘑菇应助科研通管家采纳,获得10
3分钟前
3分钟前
3分钟前
凡空发布了新的文献求助10
3分钟前
禾页完成签到 ,获得积分10
3分钟前
小蓝完成签到 ,获得积分10
3分钟前
科研牛马完成签到,获得积分10
4分钟前
金秋完成签到,获得积分0
4分钟前
HHW完成签到,获得积分10
4分钟前
战战兢兢的失眠完成签到 ,获得积分10
4分钟前
小羊完成签到,获得积分0
4分钟前
高分求助中
Principles of Economics, 11th Edition 10000
Prescott's Microbiology: 2026 Release ISE 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Environmental Leverage in Times of Climate Crisis: Product Standards, Carbon Border Measures and Preferential Trade Agreements 1000
Erwählung und Berufung bei Paulus: Bedeutung, Entwicklung und Funktion einer Vorstellung in ihrem frühjüdischen und griechisch-römischen Kontext 850
Matrix Methods in Data Mining and Pattern Recognition 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7203517
求助须知:如何正确求助?哪些是违规求助? 8837525
关于积分的说明 18651421
捐赠科研通 6849024
什么是DOI,文献DOI怎么找? 3179810
关于科研通互助平台的介绍 2337471
邀请新用户注册赠送积分活动 2154245